OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase I/II trial of neoadjuvant sunitinib administered with weekly paclitaxel/carboplatin in patients with locally advanced triple-negative breast cancer

HTML

Year: 2015
Type: article
Study design: Clinical Trial
Source: Breast Cancer Research and Treatment
DOI: 10.1007/s10549-015-3482-4
Authors: Denise A. Yardley, Dianna L. Shipley, Nancy W. Peacock, Mythili Shastry, Rajiv Midha, Victor M. Priego, John D. Hainsworth
Institutions: Sarah Cannon, Tennessee Oncology, Center for Cancers and Blood Disorders
Language: English

Topic: Breast Cancer Treatment Studies
Subfield: Cancer Research
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: triple-negative breast cancer, neoadjuvant therapy, sunitinib, paclitaxel, carboplatin, pathological complete response, locally advanced breast cancer, myelosuppression, treatment toxicity, maximum tolerated dose
SDG: Good health and well-being

Open Access status: closed

Funder: Pfizer
OpenAlex ID: W780100295
FWCI: 0.888
Cites: 36
Cited by: 18
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security